Rating History for Amylin Pharmaceuticals (AMLN) by Credit Suisse

More Stocks Rated by Credit Suisse | Latest Ratings for AMLN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/16/2012 N/A New Coverage Outperform
(N/A)		 22.00
(N/A)		 17.61
(30.98)		 75.92% Details